Region-specific Dissociation of Neuronal Loss and Neurofibrillary Pathology in a Mouse Model of Tauopathy

Cited by (402)

Items 101–200 of 402

1. Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
   Hanger, Diane P, Seereeram, Anjan, Noble, Wendy · 2009 · Expert Review of Neurotherapeutics
2. Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
   Julia E. Gerson, Kathleen M. Farmer, Natalie Henson, Diana Laura Castillo‐Carranza, Mariana Carretero Murillo, Urmi Sengupta, Alan D.T. Barrett, Rakez Kayed · 2018 · Molecular Neurodegeneration
3. Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system
   Ramirez, Paulino, Zuniga, Gabrielle, Sun, Wenyan, Beckmann, Adrian, Ochoa, Elizabeth, DeVos, Sarah L., Hyman, Bradley, Chiu, Gabriel, Roy, Ethan R., Cao, Wei et al. · 2022 · Progress in Neurobiology
4. Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity
   Emily Hill, Thomas K. Karikari, Kevin G. Moffat, Magnus J. E. Richardson, Mark John Wall · 2019 · eNeuro
5. TOC1: Characterization of a Selective Oligomeric Tau Antibody
   Sarah Ward, Diana S. Himmelstein, Jody K. Lancia, Yifan Fu, Kristina R. Patterson, Lester I. Binder · 2013 · Journal of Alzheimer s Disease
6. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
   Cristian A. Lasagna‐Reeves, Urmi Sengupta, Diana Laura Castillo‐Carranza, Julia E. Gerson, Marcos Jair Guerrero‐Munoz, Juan Carlos Troncoso, George R. Jackson, Rakez Kayed · 2014 · Acta Neuropathologica Communications
7. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load
   Peter Koson, Norbert Žilka, Andrej Kováč, Branislav Kováčech, Miroslava Korenova, Peter Filipčík, Michal Novák · 2008 · European Journal of Neuroscience
8. Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation
   Ochoa, Elizabeth, Ramirez, Paulino, Gonzalez, Elias, De Mange, Jasmine, Ray, William J., Bieniek, Kevin F., Frost, Bess · 2023 · Science Advances
9. Potential mechanisms and implications for the formation of tau oligomeric strains
   Julia E. Gerson, Amritpal K. Mudher, Rakez Kayed · 2016 · Critical Reviews in Biochemistry and Molecular Biology
10. Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease
    Jian‐Zhi Wang, Zhi-Hao Wang, Qing Tian · 2014 · Neuroscience Bulletin
11. Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
    Julia E. Gerson, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · ACS Chemical Neuroscience
12. Altered Synapse Stability in the Early Stages of Tauopathy
    Johanna Jackson, Jonathan Witton, James D. Johnson, Zeshan Ahmed, Mark Ward, Andrew D. Randall, Michael L. Hutton, John T. R. Isaac, Michael J. O’Neill, Michael C. Ashby · 2017 · Cell Reports
13. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
    Tara E. Tracy, Li Gan · 2017 · BioEssays
14. Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy
    Johanna L. Crimins, Anne B. Rocher, Alan Peters, Penny L. Shultz, Jada M. Lewis, Jennifer Irene Luebke · 2011 · Acta Neuropathologica
15. Glial Fibrillary Tangles and JAK/STAT-Mediated Glial and Neuronal Cell Death in a Drosophila Model of Glial Tauopathy
    Kenneth J. Colodner, Mel Β. Feany · 2010 · Journal of Neuroscience
16. Abnormal processing of tau in the brain of aged TgCRND8 mice
    Arianna Bellucci, Maria Cristina Rosi, Cristina Grossi, Anna Fiorentini, Ilaria Luccarini, Fiorella Casamenti · 2007 · Neurobiology of Disease
17. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510
    Ai Ishikawa, Masaki Tokunaga, Jun Maeda, Takeharu Minamihisamatsu, Masafumi Shimojo, Hiroyuki Takuwa, Maiko Ono, Ruiqing Ni, Shigeki Hirano, Satoshi Kuwabara et al. · 2018 · Journal of Alzheimer s Disease
18. Amyloid Plaque and Neurofibrillary Tangle Pathology in a Regulatable Mouse Model of Alzheimer's Disease
    Jennifer B. Paulson, Martin Ramsden, Colleen L. Forster, Mathew A. Sherman, Eileen M. McGowan, Karen H. Ashe · 2008 · American Journal Of Pathology
19. Repeated Closed Head Injury in Mice Results in Sustained Motor and Memory Deficits and Chronic Cellular Changes
    Amanda N. Bolton Hall, Binoy Joseph, J. Brelsfoard, K. Saatman · 2016 · PLoS ONE
20. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
    Blackmore, Thomas, Meftah, Soraya, Murray, Tracey Karen, Craig, Peter James, Blockeel, Anthony, Phillips, Keith, Eastwood, Brian, O’Neill, Michael J., Marston, Hugh, Ahmed, Zeshan et al. · 2017 · Alzheimer's Research & Therapy
21. What is the pathological significance of tau oligomers?
    Catherine M. Cowan, Shmma Quraishe, Amritpal K. Mudher · 2012 · Biochemical Society Transactions
22. Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
    Natàlia Crespo‐Biel, Clara Theunis, Fred VAN LEUVEN · 2012 · International Journal of Alzheimer s Disease
23. The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies
    Michel Goedert · 2016 · Alzheimer s & Dementia
24. Active c‐jun N‐terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK‐3β is required for tau aggregation
    Naruhiko Sahara, Miyuki Murayama, Bo‐Young Lee, Jung‐Mi Park, Sarita Lagalwar, Lester I. Binder, Akihiko Takashima · 2008 · European Journal of Neuroscience
25. Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
    Sebastian Scott Oakley, Mahmoud Bukar Maina, Karen E. Marshall, Youssra K. Al‐Hilaly, Charlie Harrington, Claude M. Wischik, Louise C. Serpell · 2020 · Frontiers in Neurology
26. Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem
    Kerry L. Gendreau, Garth F. Hall · 2013 · Frontiers in Neurology
27. Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging
    Travis C. Jackson, Asha Rani, Ashok Kumar, Thomas C. Foster · 2008 · Cell Death and Differentiation
28. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model
    Pia Jul, Christiane Volbracht, Inge E.M. de Jong, Lone Helboe, Anders Brandt Elvang, Jan T. Pedersen · 2015 · Journal of Alzheimer s Disease
29. Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia
    Tara L. Spires‐Jones, Leora M. Fox, Anete Rozkalne, Rose Pitstick, George A. Carlson, Aleksey G. Kazantsev · 2012 · Frontiers in Pharmacology
30. Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behavior
    Monika Bijata, Ewa Bączyńska, Franziska E. Müller, Krystian Bijata, Julia Masternak, Adam Krzystyniak, Bernadeta Szewczyk, Marcin Siwiec, Svitlana Antoniuk, Matylda Roszkowska et al. · 2022 · Cell Reports
31. Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy
    Clair A. Booth, Thomas Ridler, Tracey K. Murray, Mark A. Ward, Emily de Groot, Marc Goodfellow, Keith Geoffrey Phillips, Andrew D. Randall, Jon T. Brown · 2016 · Journal of Neuroscience
32. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model
    Lone Helboe, Jan Egebjerg, Pernille Barkholt, Christiane Volbracht · 2017 · Brain Research
33. Common mouse models of tauopathy reflect early but not late human disease
    Kathrin Wenger, Arthur Viodé, Christoph N. Schlaffner, Patrick van Zalm, Long Cheng, Tammy Dellovade, Xavier Langlois, Anthony W. Bannon, Rui Chang, Theresa R. Connors et al. · 2023 · Molecular Neurodegeneration
34. Co-expression of truncated and full-length tau induces severe neurotoxicity
    Sefika Özcelik, Frederik Sprenger, Zhiva Kalinova Skachokova, G Fraser, Dorothée Abramowski, Florence Clavaguera, A. Probst, Stephan Frank, Mathias M. Müller, Matthias Staufenbiel et al. · 2016 · Molecular Psychiatry
35. Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease
    José Jaime Jarero-Basulto, José Luna‐Muñoz, Raúl Mena, Zdena Krištofíková, Daniela Řı́pová, George L. Perry, Lester I. Binder, Francisco García‐Sierra · 2013 · Journal of Neuropathology & Experimental Neurology
36. Age-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticles
    Micaela Johanna Glat, Hadas Skaat, Noa Menkes-Caspi, Shlomo Margel, Edward A Stern · 2013 · Journal of Nanobiotechnology
37. PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer’s disease
    Masuo Ohno · 2017 · Brain Research Bulletin
38. Tau acts as a mediator for<scp>A</scp>lzheimer's disease‐related synaptic deficits
    Liao, Dezhi, Miller, Eric C., Teravskis, Peter J. · 2014 · European Journal of Neuroscience
39. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
    Anastasie Maté de Gérando, Lindsay A. Welikovitch, Anita Khasnavis, Caitlin Commins, Calina A. Glynn, Joshua E Chun, Romain Perbet, Bradley T. Hyman · 2023 · Acta Neuropathologica
40. Systems biology of neurodegenerative diseases
    Levi Benjamin Wood, Ashley R. Winslow, Samantha Dale Strasser · 2015 · Integrative Biology
41. Tauopathy models and human neuropathology: similarities and differences
    S. Frank, F. Clavaguera, M. Tolnay · 2007 · Acta Neuropathologica
42. IGF-1 and pAKT Signaling Promote Hippocampal CA1 Neuronal Survival Following Injury to Dentate Granule Cells
    Robert N. Wine, Christopher A. McPherson, Gaylia Jean Harry · 2009 · Neurotoxicity Research
43. Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
    Magisetty Obulesu, R. Venu, R. Somashekhar · 2011 · Neurochemical Research
44. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
    Lixin Song, Sherry X. Lu, Xuesong Ouyang, Jerry P. Melchor, Julie Lee, Giuseppe Terracina, Xiaohai Wang, Lynn A. Hyde, J. Fred Hess, Eric M. Parker et al. · 2015 · Molecular Neurodegeneration
45. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat
    Marie d’Orange, Gwenaëlle Aurégan, Dimitri Cheramy, Mylène Gaudin, Sarah Lieger, Martine Guillermier, Lev Stimmer, Charlène Joséphine, Anne‐Sophie Hérard, Marie‐Claude Gaillard et al. · 2017 · Brain
46. Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
    Nicole M. Maphis, Julianne Peabody, Erin Crossey, Shanya Jiang, Fadi Ali Jamaleddin Ahmad, María Javiera Álvarez, Soiba Khalid Mansoor, Amanda Yaney, Yirong Yang, Laurel O. Sillerud et al. · 2019 · npj Vaccines
47. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)
    Yang, Dewen, Xie, Zhiyong, Stephenson, Diane, Morton, Daniel, Hicks, Carol D., Brown, Tracy M., Sriram, Renuka, O'Neill, Sharon, Raunig, David, Bocan, Thomas · 2011 · NeuroImage
48. Ouabain activates transcription factor EB and exerts neuroprotection in models of Alzheimer's disease
    Ha‐Lim Song, Atanas Vladimirov Demirev, Nayoung Kim, Dong‐Hou Kim, Seung‐Yong Yoon · 2018 · Molecular and Cellular Neuroscience
49. Pseudohyperphosphorylation Causing AD-like Changes in Tau Has Significant Effects on Its Polymerization
    Qian Sun, T.C. Gamblin · 2009 · Biochemistry
50. Alzheimer's disease: Old problem, new views from transgenic and viral models
    Tomasz Jaworski, Ilse Dewachter, Claire Marie Seymour, Peter Borghgraef, Herman Devijver, Sebastian Kügler, Fred VAN LEUVEN · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
51. Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy
    Katherine J. Kopeikina, Susanne Wegmann, Rose Pitstick, George A. Carlson, Brian J. Bacskai, Rebecca A. Betensky, Bradley T. Hyman, Tara L. Spires‐Jones · 2013 · PLoS ONE
52. Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 Biogenesis
    Ali Jawaid, Bisrat T. Woldemichael, Eloïse A. Kremer, Florent Laferrière, Niharika Gaur, Tariq Afroz, Magdalini Polymenidou, Isabelle M. Mansuy · 2018 · Molecular Neurobiology
53. Quercetin mitigates memory deficits in scopolamine mice model via protection against neuroinflammation and neurodegeneration
    Juliet N. Olayinka, Anthony Taghogho Eduviere, Olusegun Adebayo Adeoluwa, Adedamola Adediran Fafure, Adeshina Adebanjo, Raymond Iduojemu Ozolua · 2022 · Life Sciences
54. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
    Pádua, Mafalda Soares, Guil-Guerrero, José L., Prates, José A. M., Lopes, Paula Alexandra · 2024 · International Journal of Molecular Sciences
55. Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease
    Manuela Polydoro, Alix de Calignon, Marc Suárez‐Calvet, Laura Sanchez, Kevin R. Kay, Samantha B. Nicholls, Allyson D. Roe, Rose Pitstick, George A. Carlson, Teresa Gómez‐Isla et al. · 2013 · Journal of Neuroscience
56. An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells
    Heinz‐Georg Jahnke, Andrée Rothermel, Ina Sternberger, Till G.A. Mack, Randy Kurz, Oliver Pänke, Frank Striggow, Andrea Anneliese Robitzki · 2009 · Lab on a Chip
57. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies
    Norbert Žilka, Miroslava Korenova, Michal Novák · 2009 · Acta Neuropathologica
58. FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics
    Adria C. LeBoeuf, Sasha F. Levy, Michelle A. Gaylord, Arnab Bhattacharya, Ambuj K. Singh, Mary Ann Jordan, Leslie Wilson, Stuart C. Feinstein · 2008 · Journal of Biological Chemistry
59. Neurofibrillary tangle-bearing neurons have reduced risk of cell death in mice with Alzheimer’s pathology
    Theodore J. Zwang, Eric del Sastre, Nina Wolf, Nancy E. Ruiz‐Uribe, Benjamin Woost, Zachary T. Hoglund, Zhanyun Fan, Joshua J Bailey, Lois Nfor, Luc Buée et al. · 2024 · Cell Reports
60. The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice
    Jack Brelstaff, Bernardino Ossola, Jonas J. Neher, Therése Klingstedt, K. Peter R. Nilsson, Michel Goedert, Maria Grazia Spillantini, Aviva M. Tolkovsky · 2015 · Frontiers in Neuroscience
61. Neuropathology of the Alzheimer's continuum: an update
    K. A. Jellinger · 2020 · Free Neuropathology
62. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy
    Helena Soler, Jonatan Dorca‐Arévalo, Marta González, Sara E. Rubio, Jesús Ávila, Eduardo Soriano, Marta Pascual · 2016 · Neurobiology of Aging
63. Tau Oligomers as Pathogenic Seeds: Preparation and Propagation In Vitro and In Vivo
    Julia E. Gerson, Urmi Sengupta, Rakez Kayed · 2016 · Methods in molecular biology
64. Automated Cell Counts on Tissue Sections by Deep Learning and Unbiased Stereology
    Saeed S. Alahmari, Dmitry B. Goldgof, Lawrence Hall, Hady Ahmady Phoulady, Raj H. Patel, Peter R. Mouton · 2018 · Journal of Chemical Neuroanatomy
65. Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches
    Emily Hill, Mark John Wall, Kevin G. Moffat, Thomas K. Karikari · 2020 · Frontiers in Molecular Neuroscience
66. Modeling of Tau-Mediated Synaptic and Neuronal Degeneration in Alzheimer's Disease
    Tomasz Jaworski, Sebastian Kügler, Fred VAN LEUVEN · 2010 · International Journal of Alzheimer s Disease
67. Toward Development of Neuron Specific Transduction After Systemic Delivery of Viral Vectors
    Dylan J. Finneran, Ikenna P. Njoku, Diego Flores-Pazarin, Meghana Ranabothu, Kevin R. Nash, David Morgan, Marcia N. Gordon · 2021 · Frontiers in Neurology
68. Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
    Naruhiko Sahara, Rin Yanai · 2023 · Frontiers in Neuroscience
69. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord
    Jennifer A. Macdonald, Iraad F. Bronner, Lesley F. Drynan, Juan Fan, Annabelle Curry, Graham Mathew Fraser, Isabelle Lavenir, Michel Goedert · 2019 · Acta Neuropathologica Communications
70. Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
    Yu Young Jeong, Sinsuk Han, Nuo Jia, Mingyang Zhang, Preethi Sheshadri, Prasad Tammineni, Jasmine Cheung, Marialaina Nissenbaum, Sindhuja S Baskar, Kelvin Y. Kwan et al. · 2021 · Brain
71. Hyperphosphorylation of microtubule-associated tau protein plays dual role in neurodegeneration and neuroprotection
    Yao Zhang, Qing Tian, Qi Zhang, Xinwen Zhou, Shijie Liu, Jian‐Zhi Wang · 2009 · Pathophysiology
72. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
    Tara L. Spires‐Jones, Taylor Friedman, Rose Pitstick, Manuela Polydoro, Allyson D. Roe, George A. Carlson, Bradley T. Hyman · 2014 · Neuroscience Letters
73. In vivo functional brain mapping in a conditional mouse model of human tauopathy (taup301l) reveals reduced neural activity in memory formation structures
    Pablo D. Pérez, Gabrielle Hall, Tetsuya Kimura, Yan Ren, Rachel M. Bailey, Jada M. Lewis, Marcelo Febo, Naruhiko Sahara · 2013 · Molecular Neurodegeneration
74. Zebrafish models of Tauopathy
    Qing Bai, Edward A. Burton · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
75. Invited review: Drug development for tauopathies
    Fiona Grüninger · 2014 · Neuropathology and Applied Neurobiology
76. A Powerful Yeast Model to Investigate the Synergistic Interaction of α-Synuclein and Tau in Neurodegeneration
    Gianmario Ciaccioli, Ana Martins, Cátia Rodrigues, Helena Vieira, Patrícia Calado · 2013 · PLoS ONE
77. Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers
    Catherine M. Cowan, Shmma Quraishe, Sarah L. Hands, Megan A. Sealey, Sumeet Mahajan, Douglas W. Allan, Amritpal K. Mudher · 2015 · Scientific Reports
78. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
    Urmi Sengupta, Nicha Puangmalai, Nemil N. Bhatt, Stephanie García, Yingxin Zhao, Rakez Kayed · 2020 · Molecular Neurobiology
79. Yeast as a Model System to Study Tau Biology
    Ann De Vos, Jayamani Anandhakumar, Jeff Van den Brande, Mathias Verduyckt, Vanessa Franssens, Joris Winderickx, Erwin Swinnen · 2011 · International Journal of Alzheimer s Disease
80. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration
    Christopher M. Holton, N. Hanley, E. Shanks, Penny Oxley, Andrew P. McCarthy, Brian J. Eastwood, Tracey K. Murray, Aidan P. Nickerson, K. A. Wafford · 2020 · Alzheimer s Research & Therapy
81. GSK-3β and memory formation
    Akihiko Takashima · 2012 · Frontiers in Molecular Neuroscience
82. Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer’s disease
    Callum Walsh, Wilhelmus H. I. M. Drinkenburg, Abdallah Ahnaou · 2016 · Neuroscience & Biobehavioral Reviews
83. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies
    Zein Amro, Andrea J. Yool, Lyndsey E. Collins‐Praino · 2021 · Brain Behavior & Immunity - Health
84. Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration
    Andrew R. Mendelsohn, James W. Larrick · 2018 · Rejuvenation Research
85. Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline
    Ari W. Schaler, Natura Myeku · 2017 · Translational research
86. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
    Dylan J. Finneran, David Morgan, Marcia N. Gordon, Kevin R. Nash · 2018 · Journal of Neuroimmune Pharmacology
87. Study the Longitudinal in vivo and Cross-Sectional ex vivo Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural Parcellation
    Ma, Da, Holmes, Holly E., Cardoso, Manuel J., Modat, Marc, Harrison, Ian F., Powell, Nick M., O’Callaghan, James M., Ismail, Ozama, Johnson, Ross A., O’Neill, Michael J. et al. · 2019 · Frontiers in Neuroscience
88. A Peephole into the Brain: Neuropathological Features of Alzheimer’s Disease Revealed by in vivo Two-Photon Imaging
    Sabine Liebscher, Melanie Meyer‐Luehmann · 2012 · Frontiers in Psychiatry
89. Sources of Extracellular Tau and its Signaling
    Jesús Ávila, Diana Simón, Miguel Dı́az-Hernández, Jesús J. Pintor, Félix Hernández · 2014 · Journal of Alzheimer s Disease
90. Tau in MAPK Activation
    Chad J. Leugers, Ju Yong Koh, Willis Hong, Gloria S. Lee · 2013 · Frontiers in Neurology
91. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration
    Luka Kulic, Marc Axel Wollmer, Virginie F. Rhein, Lucia Pagani, Katrin Kuehnle, Susann Cattepoel, Jay Tracy, Anne Eckert, Roger M. Nitsch · 2009 · Neurobiology of Aging
92. Plasticity in visual cortex is disrupted in a mouse model of tauopathy
    Amalia Papanikolaou, Fábio Ribeiro Rodrigues, Joanna Holeniewska, Keith Geoffrey Phillips, Aman B. Saleem, Samuel G. Solomon · 2022 · Communications Biology
93. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
    Bailey, Rachel M, Howard, John, Knight, Joshua, Sahara, Naruhiko, Dickson, Dennis W, Lewis, Jada · 2014 · Molecular Neurodegeneration
94. Apoptosis in Transgenic Mice Expressing the P301L Mutated Form of Human Tau
    Rita M. Ramalho, Ricardo J.S. Viana, Rui Eduardo Castro, Clifford J. Steer, Walter C. Low, Cecília M. P. Rodrigues · 2008 · Molecular Medicine
95. Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses
    Rudinskiy, Nikita, Hawkes, Jonathan M, Wegmann, Susanne, Kuchibhotla, Kishore V, Muzikansky, Alona, Betensky, Rebecca A, Spires-Jones, Tara L, Hyman, Bradley T · 2014 · Acta Neuropathologica Communications
96. Three‐repeat and four‐repeat tau isoforms form different oligomers
    Hedieh Shahpasand‐Kroner, Jennifer Portillo, Carter Lantz, Paul M. Seidler, Natalie Sarafian, Joseph A. Loo, Gal Bitan · 2021 · Protein Science
97. Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1–42) induced neurotoxicity in animal model of Alzheimer’s disease
    Swati Som, Justin Antony, S. P. Dhanabal, Sivasankaran Ponnusankar · 2022 · Metabolic Brain Disease
98. The metamorphic nature of the Tau protein: dynamic flexibility comes at a cost
    Sabbagh, Jonathan J., Dickey, Chad A. · 2016 · Frontiers in Neuroscience
99. An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
    Fokion Spanos, Shane Antony Liddelow · 2020 · Cells
100. Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
     Yu Young Jeong, Sinsuk Han, Nuo Jia, Mingyang Zhang, Preethi Sheshadri, Prasad Tammineni, Jasmine Cheung, Marialaina Nissenbaum, Sindhuja S. Baskar, Kelvin Y. Kwan et al. · 2022 · UCL Discovery (University College London)